• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lung disease in rheumatoid arthritis.类风湿关节炎中的肺部疾病
Rheum Dis Clin North Am. 2015 May;41(2):225-36. doi: 10.1016/j.rdc.2014.12.004. Epub 2015 Feb 3.
2
Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).纤维化性间质性肺炎可预测类风湿关节炎相关间质性肺病(RA-ILD)患者的生存情况。
Respir Med. 2013 Aug;107(8):1247-52. doi: 10.1016/j.rmed.2013.05.002. Epub 2013 Jun 19.
3
Pulmonary involvement in rheumatoid arthritis.类风湿关节炎的肺部受累
Semin Arthritis Rheum. 1995 Feb;24(4):242-54. doi: 10.1016/s0049-0172(95)80034-4.
4
[Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis].[类风湿关节炎相关间质性肺疾病的诊断与治疗问题]
Ter Arkh. 2013;85(5):84-91.
5
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.类风湿关节炎相关间质性肺疾病(RA-ILD):甲氨蝶呤与肺部疾病严重程度与预后相关。
Clin Rheumatol. 2017 Jul;36(7):1493-1500. doi: 10.1007/s10067-017-3707-5. Epub 2017 Jun 6.
6
The lung in rheumatoid arthritis.类风湿关节炎中的肺脏
Presse Med. 2011 Jan;40(1 Pt 2):e31-48. doi: 10.1016/j.lpm.2010.11.003. Epub 2010 Dec 31.
7
Rheumatoid arthritis and lung disease: from mechanisms to a practical approach.类风湿关节炎与肺部疾病:从发病机制到实际应对方法
Semin Respir Crit Care Med. 2014 Apr;35(2):222-38. doi: 10.1055/s-0034-1371542. Epub 2014 Mar 25.
8
Pulmonary manifestations of rheumatoid arthritis.类风湿关节炎的肺部表现
Semin Respir Crit Care Med. 2007 Aug;28(4):430-40. doi: 10.1055/s-2007-985664.
9
Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.类风湿关节炎相关间质性肺疾病:关联、预后因素以及生理和放射学特征——一项大型多中心英国研究。
Rheumatology (Oxford). 2014 Sep;53(9):1676-82. doi: 10.1093/rheumatology/keu165. Epub 2014 Apr 23.
10
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.类风湿关节炎患者的肺部受累和药物性肺疾病。
Expert Rev Clin Immunol. 2013 Jul;9(7):649-57. doi: 10.1586/1744666X.2013.811173.

引用本文的文献

1
Telomere Shortening in Interstitial Lung Disease: Challenges and Promises.间质性肺疾病中的端粒缩短:挑战与前景
Clin Respir J. 2025 Jul;19(7):e70103. doi: 10.1111/crj.70103.
2
Review of pulmonary manifestations of rheumatoid arthritis.类风湿关节炎肺部表现的综述。
Skeletal Radiol. 2025 May 17. doi: 10.1007/s00256-025-04930-5.
3
Bronchiolar disorders in systemic autoimmune rheumatic diseases.系统性自身免疫性风湿疾病中的细支气管疾病
Eur Respir Rev. 2025 Apr 16;34(176). doi: 10.1183/16000617.0248-2024. Print 2025 Apr.
4
ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis.抗环瓜氨酸肽抗体(ACPA)是类风湿关节炎患者经CT证实的肺结节进展的主要危险因素。
Clin Rheumatol. 2025 Mar;44(3):1031-1040. doi: 10.1007/s10067-025-07344-9. Epub 2025 Jan 30.
5
Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study.新诊断且未治疗的类风湿关节炎和银屑病关节炎的肺部受累情况:一项前瞻性纵向研究。
Rheumatol Int. 2024 Dec 18;45(1):3. doi: 10.1007/s00296-024-05751-w.
6
Real-World Clinical Effectiveness and Safety of Antifibrotics in Progressive Pulmonary Fibrosis Associated with Rheumatoid Arthritis.抗纤维化药物在类风湿关节炎相关进行性肺纤维化中的真实世界临床疗效与安全性
J Clin Med. 2024 Nov 22;13(23):7074. doi: 10.3390/jcm13237074.
7
What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?我们从类风湿关节炎中抑制白细胞介素-6的研究中学到了什么,对患者预后有哪些临床机遇?
Ther Adv Musculoskelet Dis. 2024 Oct 21;16:1759720X241283340. doi: 10.1177/1759720X241283340. eCollection 2024.
8
Multiple Pulmonary Involvement in the Rapidly Progressive Evolution of Rheumatoid Arthritis.类风湿关节炎快速进展期的多肺受累
Diagnostics (Basel). 2024 Sep 29;14(19):2175. doi: 10.3390/diagnostics14192175.
9
Acute exacerbation of interstitial lung disease after transthoracic biopsy.经胸壁活检后间质性肺疾病急性加重
J Bras Pneumol. 2024 Sep 27;50(4):e20230426. doi: 10.36416/1806-3756/e20230426.
10
Moving forward in Rheumatoid Arthritis-Associated Interstitial Lung Disease Screening.类风湿关节炎相关间质性肺疾病筛查的进展
J Clin Med. 2024 Sep 11;13(18):5385. doi: 10.3390/jcm13185385.

本文引用的文献

1
Rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病
Open Access Rheumatol. 2012 Mar 5;4:21-31. doi: 10.2147/OARRR.S14723. eCollection 2012.
2
Biomarkers of rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病的生物标志物。
Arthritis Rheumatol. 2015 Jan;67(1):28-38. doi: 10.1002/art.38904.
3
Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation.类风湿关节炎相关间质性肺病肺移植术后的生存和生活质量。
J Heart Lung Transplant. 2014 May;33(5):514-20. doi: 10.1016/j.healun.2014.01.858. Epub 2014 Jan 24.
4
Predictors of mortality in rheumatoid arthritis-related interstitial lung disease.类风湿关节炎相关间质性肺疾病患者的死亡预测因素。
Respirology. 2014 May;19(4):493-500. doi: 10.1111/resp.12234. Epub 2013 Dec 26.
5
Rituximab in severe, treatment-refractory interstitial lung disease.利妥昔单抗治疗严重、治疗抵抗性间质性肺疾病。
Respirology. 2014 Apr;19(3):353-9. doi: 10.1111/resp.12214. Epub 2013 Nov 29.
6
When and where does inflammation begin in rheumatoid arthritis?类风湿关节炎中的炎症何时何地开始?
Curr Opin Rheumatol. 2014 Jan;26(1):64-71. doi: 10.1097/BOR.0000000000000017.
7
Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.类风湿关节炎中 DMARDs 和生物制剂诱发或加重的间质性肺疾病:系统文献回顾。
Semin Arthritis Rheum. 2014 Apr;43(5):613-26. doi: 10.1016/j.semarthrit.2013.09.005. Epub 2013 Oct 5.
8
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.美国胸科学会/欧洲呼吸学会官方声明:特发性间质性肺炎的国际多学科分类的更新。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.
9
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.类风湿关节炎患者的肺部受累和药物性肺疾病。
Expert Rev Clin Immunol. 2013 Jul;9(7):649-57. doi: 10.1586/1744666X.2013.811173.
10
Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease.已确诊类风湿性关节炎患者及未来有临床明显疾病风险受试者的痰液自身抗体
Arthritis Rheum. 2013 Oct;65(10):2545-54. doi: 10.1002/art.38066.

类风湿关节炎中的肺部疾病

Lung disease in rheumatoid arthritis.

作者信息

Yunt Zulma X, Solomon Joshua J

机构信息

Autoimmune Lung Center, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.

Autoimmune Lung Center, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.

出版信息

Rheum Dis Clin North Am. 2015 May;41(2):225-36. doi: 10.1016/j.rdc.2014.12.004. Epub 2015 Feb 3.

DOI:10.1016/j.rdc.2014.12.004
PMID:25836639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4415514/
Abstract

Rheumatoid arthritis (RA) affects approximately 1% of the US population frequently has extra-articular manifestations. Most compartments of the lung are susceptible to disease. Interstitial lung disease (ILD) and airways disease are the most common forms of RA-related lung disease. RA-ILD carries the worst prognosis and most often manifests in a histologic pattern of usual interstitial pneumonia or nonspecific interstitial pneumonia. There have been no large, well-controlled prospective studies investigating therapies for RA-ILD. Treatment usually entails immunomodulatory agents. Further studies are needed to better understand pathogenic mechanisms of disease that lead to lung involvement in these patients.

摘要

类风湿性关节炎(RA)影响着约1%的美国人口,常伴有关节外表现。肺部的大多数区域都易患此病。间质性肺疾病(ILD)和气道疾病是类风湿性关节炎相关肺部疾病最常见的形式。类风湿性关节炎相关间质性肺疾病预后最差,最常表现为普通型间质性肺炎或非特异性间质性肺炎的组织学模式。目前尚无大型、严格对照的前瞻性研究来调查类风湿性关节炎相关间质性肺疾病的治疗方法。治疗通常需要使用免疫调节剂。需要进一步研究以更好地了解导致这些患者肺部受累的疾病致病机制。